Literature DB >> 8807140

The causes of essential hypertension.

M J Brown1.   

Abstract

1. Confusion between the criteria for defining and diagnosing hypertension may have misled the search for the causes of hypertension. 2. The systematic approach of molecular genetics appears to offer the best chance of explaining hypertension, but the attractions are partly offset by the large numbers required, and unproven record of the genetic techniques in finding functional mutations in complex human disorders. 3. Part of the evidence for the polygenic nature of essential hypertension derives from the variable response to a large number of different anti-hypertensive agents. Systematic investigation of this variability may provide a basis for dividing patients into genetically more homogeneous sub-groups, within which smaller numbers will be required to detect the genes responsible for the susceptibility to hypertension. 4. The proportion of hypertensive patients with affected siblings has been studied in 6000 patients from Addenbrookes Hospital and local general practices. A recurrence risk for hypertension of approximately 3.5 was found. 5. Approximately two-thirds of patients have no known affected siblings. The next largest group, about one third, is patients whose siblings are all hypertensive. In a small group, < 10% of all patients, half the siblings are hypertensive. 6. We conclude from these surprising findings that hypertension is not a continuous, multifactorial part of the normal blood pressure distribution. They suggest that several more single-gene disorders causing hypertension will be found. The sibships where all members are hypertensive are inconsistent with the segregation of Mendelian genetics and suggest the selection of some genes linked to hypertension at the time of gamete maturation.

Entities:  

Mesh:

Year:  1996        PMID: 8807140      PMCID: PMC2042644          DOI: 10.1046/j.1365-2125.1996.03785.x

Source DB:  PubMed          Journal:  Br J Clin Pharmacol        ISSN: 0306-5251            Impact factor:   4.335


  7 in total

Review 1.  Linkage mapping for hypertension susceptibility genes.

Authors:  N Kato; C Julier
Journal:  Curr Hypertens Rep       Date:  1999 Feb-Mar       Impact factor: 5.369

Review 2.  Pathoaetiology, epidemiology and diagnosis of hypertension.

Authors:  M J Brown; S Haydock
Journal:  Drugs       Date:  2000       Impact factor: 9.546

Review 3.  Genetics of hypertension. Therapeutic implications.

Authors:  S O'Byrne; M Caulfield
Journal:  Drugs       Date:  1998-08       Impact factor: 9.546

Review 4.  The genetics of essential hypertension.

Authors:  K M O'Shaughnessy
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

5.  Genomic Research in Postmenopausal Hypertension.

Authors:  Costas Thomopoulos
Journal:  J Clin Hypertens (Greenwich)       Date:  2015-03-31       Impact factor: 3.738

Review 6.  Is There a Role for Genomics in the Management of Hypertension?

Authors:  Jacopo Burrello; Silvia Monticone; Fabrizio Buffolo; Martina Tetti; Franco Veglio; Tracy A Williams; Paolo Mulatero
Journal:  Int J Mol Sci       Date:  2017-05-26       Impact factor: 5.923

Review 7.  Genes for blood pressure: an opportunity to understand hypertension.

Authors:  Georg B Ehret; Mark J Caulfield
Journal:  Eur Heart J       Date:  2013-01-09       Impact factor: 29.983

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.